MedPath

TRODELVY

TRODELVY

Approved
DIN Number

02520788

Drug Class

Human

Market Date

Nov 22, 2021

Company
HC

gilead sciences canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02520788
AIG Number0163175001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01FX17 SACITUZUMAB GOVITECAN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SACITUZUMAB GOVITECANActive
Strength: 180 MG / VIAL
Monograph: SACITUZUMAB GOVITECAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.